Hendriksz TR - Search Results

1

Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapy.

van der Bilt FE, Hendriksz TR, van der Meijden WA, Brilman LG, van Bommel EF. van der Bilt FE, et al. Among authors: hendriksz tr. Clin Kidney J. 2016 Apr;9(2):184-91. doi: 10.1093/ckj/sfv148. Epub 2016 Jan 18. Clin Kidney J. 2016. PMID: 26985367 Free PMC article.

2

Elevated serum IgG4 levels in diagnosis and treatment response in patients with idiopathic retroperitoneal fibrosis.

Pelkmans LG, Hendriksz TR, Westenend PJ, Vermeer HJ, van Bommel EFH. Pelkmans LG, et al. Among authors: hendriksz tr. Clin Rheumatol. 2017 Apr;36(4):903-912. doi: 10.1007/s10067-017-3542-8. Epub 2017 Jan 19. Clin Rheumatol. 2017. PMID: 28105551

3

Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone.

van Bommel EF, Siemes C, Hak LE, van der Veer SJ, Hendriksz TR. van Bommel EF, et al. Among authors: hendriksz tr. Am J Kidney Dis. 2007 May;49(5):615-25. doi: 10.1053/j.ajkd.2007.02.268. Am J Kidney Dis. 2007. PMID: 17472843

4

Clinical value of gallium-67 SPECT scintigraphy in the diagnostic and therapeutic evaluation of retroperitoneal fibrosis: a prospective study.

van Bommel EF, Siemes C, van der Veer SJ, Han SH, Huiskes AW, Hendriksz TR. van Bommel EF, et al. Among authors: hendriksz tr. J Intern Med. 2007 Aug;262(2):224-34. doi: 10.1111/j.1365-2796.2007.01805.x. J Intern Med. 2007. PMID: 17645590 Free article.

5

Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation.

van Bommel EFH, Jansen I, Hendriksz TR, Aarnoudse ALHJ. van Bommel EFH, et al. Among authors: hendriksz tr. Medicine (Baltimore). 2009 Jul;88(4):193-201. doi: 10.1097/MD.0b013e3181afc420. Medicine (Baltimore). 2009. PMID: 19593223 Free article.

6

(18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.

Jansen I, Hendriksz TR, Han SH, Huiskes AW, van Bommel EF. Jansen I, et al. Among authors: hendriksz tr. Eur J Intern Med. 2010 Jun;21(3):216-21. doi: 10.1016/j.ejim.2010.02.008. Epub 2010 Mar 28. Eur J Intern Med. 2010. PMID: 20493425 Clinical Trial.

7

Pseudocyst formation in retroperitoneal fibrosis relapse.

Jansen I, Hendriksz TR, Van Bommel EF. Jansen I, et al. Among authors: hendriksz tr. Br J Radiol. 2010 Jun;83(990):e111-3. doi: 10.1259/bjr/81915147. Br J Radiol. 2010. PMID: 20505023 Free PMC article.

8

Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis.

van Bommel EF, Pelkmans LG, van Damme H, Hendriksz TR. van Bommel EF, et al. Among authors: hendriksz tr. Eur J Intern Med. 2013 Jul;24(5):444-50. doi: 10.1016/j.ejim.2012.11.010. Epub 2012 Dec 13. Eur J Intern Med. 2013. PMID: 23246124

9

Abdominal aortic diameter and cardiovascular status in patients with idiopathic retroperitoneal fibrosis.

Kharagjitsing HHS, van Vooren J, Brilman EG, Hendriksz TR, van Gelder T, van Bommel EFH. Kharagjitsing HHS, et al. Among authors: hendriksz tr. Rheumatol Int. 2022 Jul;42(7):1167-1175. doi: 10.1007/s00296-021-05051-7. Epub 2021 Nov 25. Rheumatol Int. 2022. PMID: 34821970

10

Clinical significance of soluble interleukin-2 receptor measurement in patients with idiopathic retroperitoneal fibrosis.

Kharagjitsing HHS, Hendriksz TR, Fouraux MA, van Gelder T, van Bommel EFH. Kharagjitsing HHS, et al. Among authors: hendriksz tr. Int Urol Nephrol. 2022 Oct;54(10):2663-2671. doi: 10.1007/s11255-022-03196-3. Epub 2022 Mar 31. Int Urol Nephrol. 2022. PMID: 35359217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters